Birmingham, United Kingdom

Visit us

effective innovations reliable solutions More information Full cycle clinical evaluations for medical devices, diagnostic and pharmaceutics Learn more the Health Care industry in there
transformation to Health
Management Companies
We support More information

About us

SynapCon was founded in 2006 to supply technical and organizational services for clinical drug development.

Following the founding idea of SynapCon, we focused on the development and marketing of outstanding IT solutions.

This focus also allows us to work for clinical service providers.

Our products are developed in collaboration with excellent development teams and specialists.

In close cooperation with our customers and many other market players, we are working to realize our common vision of providing optimal and affordable medical care worldwide.

Early Bird - Contact us now to receive special conditions (sales(at)synapcon.com)!

Shorten your clinical research processes by using our CTMS system EasyClin(c), the eTMF will convince you and the optional eISF will inspire your study centers. Sign up for a demonstration today (sales(at)synapcon.com).

Custom icon
Need your customized enterprise solution? - contact us today (sales(at)synapcon.com)!

Clinical Research proven GDPR conform Videoconferencing platform

Reduce the number of on-site visits and meetings in your clinical research studies.

For more information and registration for free, follow this link: https://synapcon.com/study-site-selection/

The Clinical Trial Feasibility study evaluates the possibility of conducting a particular clinical program / trial in a particular geographical region with the overall objective of optimum project completion in terms of study site competencies, patient population, timelines, targets and cost.

Only the harmonious interaction of professional expertise combined with outstanding skills in technical development creates the prerequisites for creating complex architectures.

Our vision

A digital health approach that makes a difference for all stakeholders (including patients, doctors & payers) by IT powered management of drug and medical device development. It is our vision to innovate the clinical trials world through disrupting outdated processes and organizational structures.

Our innovative solutions optimize the interfaces between patient data, clinics and the industry that develops drugs and medical devices.
This includes the implementation of our digital solutions and coordinated consulting to optimize your processes.
You benefit from our market knowledge of the entire medical value chain.
Our goal is to provide our customers with profitable advantages from the current challenges of the market.
Our commitment and technical expertise helps shorten development cycles to ensure faster patient care and reduce development costs to make innovative medicines affordable.

Target Market

Diagnostics & medical device companies 
Pharmaceutical companies
Biotechnology companies
 

Target Market

Institutions, patient organizations, charities and researching hospitals
Diagnostics & medical device companies 
Pharmaceutical companies
Biotechnology companies
Service Providers
 

A digital health approach that makes a difference for all stakeholders (including patients, doctors & payers) by IT powered management of drug and medical device development. It is our vision to innovate the clinical trials world through disrupting outdated processes and organizational structures.

Change the game – use software solutions to perform clinical research projects more efficiently then ever before.

Our business model combines innovative IT product solutions and related consultancy support implemented by a lean organization built of IT-affine, curious, entrepreneurial, self responsible people & supported by our competitive FIDAS strategy.

Competitive Advantage

Our unique approach of Rethinking Clinical Research Operations

Focused│Integrated│Digitised│Automatised│Specialised (FIDAS)

Our proprietary IT systems:  EasyClin© & CLiNSTORM©

Use our EU-GDPR compliant videoconferencing system to reduce the number of patient visits in your clinical research projects

Competitive Advantage

Our unique approach of Rethinking Clinical Research Operations

Focused│Integrated│Digitised
Automatised│Specialised (FIDAS)

Our proprietary IT systems:  EasyClin© & CLiNSTORM© (artificial intelligence based solution in development )

Our enterprises

SynapCon Group develops new ways to set standards in clinical research through digital transformation.
We provide consultancy practice within the health market, investors and business arena

Success is at the heart of every project. We are committed to being a pillar of your success at all levels. Our unique approach is to rethink the Clinical Research approach by combining the latest IT solutions with clinical operations services to improve the value chains. This hybrid model ultimately forms the SynapCon Group’s innovative approach called CROIT (Clinical Research Operations Information Technology).

We help companies evolve within the complex healthcare environment. Our team of professionals supports companies in their development from a clinical, financial and entrepreneurial point of view.
Cutting-edge solutions through new thinking

We are optimizing interfaces between patient data, clinics and industry developing drugs and medical devices. Our mission is to implement a structure, based on a novel organizational partner structure and digital technologies. Our goals are: to positively influence the medical value chain in the health market to generate benefits for the community, this means, shortening development cycles to ensure faster patient care and reducing development costs to make innovative medicine affordable.

Our unique approach of Rethinking Clinical Research Operations is to build IT systems to further increase innovation within the clinical research market.
Efficently manage clinical research studies

Our Software solutions reduce the number of platforms in clinical research and, consequently, the costs of validating interfaces, maintenance, support and training. Our software reduces the time to market and extends the patent-protected marketing of your products. We always keep our eyes on the patients, providing people with a faster access to life-saving medical products is our driving force and shapes our actions.

EasyClin© is a newly designed platform and cost-effective software solution for your clinical research projects. This system will  be the core of your study communication.

The system is designed to cover all requirements from the strictest regulations in Europe (EU-GDPR), US (21CFR Part 11) and ICH-GCP E6 R2.

The EasyClin(c) project has received funding from the European Union’s Horizon 2020 research and Innovation programme under grant Agreement No 691546

EasyClin© provides an integrated and regulatory compliant platform to effectively and efficiently manage clinical research studies.

Together with our partner AIFINITY Holding Ltd., we are developing the CLiNSTORM© system, using state-of-the-art technologies sustainably changing the expensive way of performing clinical research studies.

The first module is available serving our page visitors with the most current clinical research information.

This service is for free.

Information Centre

The CLiNSTORM© solution through its AI capabilities addresses central Clinical Research challenges

EasyVideo is a GDPR compliant peer-to-peer videoconferencing tool.

It is a safe and multilanguage tool supporting the communication between investigators and study subjects as well as between clinical monitors and investigators.

EasyVideo meets all requirements of GDPR, CCPA, 21 CFR Part 11 and is therefore safe to use in clinical studies.

The EasyVideo solution is ideal for use in demanding regulatory systems
We provide consultancy practice within the health market, finance and business arena

Success is at the heart of every project. We are committed to being a pillar of your success at all levels. Our unique approach is supporting our customers  rethinking the Clinical Research approach by combining the latest IT solutions with clinical operations services to improve the value chains. This hybrid model ultimately forms the SynapCon Group’s innovative approach called CROIT (Clinical Research Operations Information Technology).

We help companies evolve within the complex healthcare environment. Our team of professionals supports companies in their development from a clinical, financial and entrepreneurial point of view.

Driving innovation through proprietary IT systems

We operate as a “Clinical Research Organization” (CRO) which optimizes interfaces between patient data, clinics and industry developing drugs and medical devices. Our mission is to implement a CRO 4.0, based on a novel organizational structure and digital technologies. Our goals are: taking profitable advantages out of current challenges in the CRO market to generate values, shortening development cycles to ensure faster patient care and reducing development costs to make innovative medicine affordable.

Our unique approach of Rethinking Clinical Research Operations (CROs) is to build IT systems to further increase innovation within the clinical research market.

Efficently manage clinical research studies

Our Software solutions reduce the number of platforms in clinical research and, consequently, the costs of validating interfaces, maintenance, support and training. Our software reduces the time to market and extends the patent-protected marketing of your products. We always keep our eyes on the patients, providing people with a faster access to life-saving medical products is a driving force and shapes our actions.

EasyClin© is a newly designed platform and cost-effective software solution for your clinical research projects. Following the successful release of our application to conduct clinical feasibility studies, we are pleased to welcome you to our Management System today. This system (and today it will gain access to the important area of document management) will in future be the core of your study communication. The type of access and availability are based on the social networks in the future. The authorization management fulfills the highest requirements also from the side of the regulators. Our three-way staggered hybrid model grows to meet your needs. Take care of the essentials, leave the rest to technology.

EasyClin provides an integrated and regulatory compliant platform to effectively and efficiently manage clinical research studies supported by the European Commission.

CLiNSTORM triples clinical research cost effciency and speed

CLiNSTORM©’s core business is delivering a smart and low cost cloud-client based solution for organizations to manage their clinical trials of medical devices, diagnostics and biopharmaceutics.

CLiNSTORM© is the brand of the organization as well as the name for the comprehensive solution offered. As the brand name suggests CLiNSTORM© will take the market by storm. This enabled by its revolutionary business model by being the first business within the clinical research industry that lets the customer pay by what they use; pay pro data point.

The CLiNSTORM© solution looks to meet the need of this target group of delivering a very scalable low cost solution.

Clinical executive team

Synapcon is managed by a highly experienced team, with offices throughout Europe and a global network of clients.
CEO, CIO & Founder of SynapCon Ltd., co-founder and COO of SWIL Systems GmbH

Biotechnologist, Clinical Researcher, 20 years of entrepreneurial experience, deep insight in the whole value chain of bio-pharmaceutical and medical product development, organisation and software developer, visionary and strategic thinking with the power to translate knowledge and information into products.

HR Manager SynapCon Group

Head Talent Acquisition & Development, MBA (International Marketing) & Business Coach (DBVC), 17 years experience in the search, selection and development of specialist and executive staff in the life science industry, Founder and CEO of PHARECON (executive search company with life science focus in Europe).

COO of SynapCon Ltd., CEO & Founder of SWIL Systems GmbH

Entrepreneur, Economist, Physical Therapist, +10 years entrepreneurial experience, +9 years of experience in health care and physical training optimisation. Active project management & lean software development, for videoconferencing and calendar tools in digital healthcare. Developer of the first and only independently audited B2C videoconferencing platform for doctors & physician in Germany, in accordance with GDPR standards and federal medical association videoconferencing conditions.

CFO and co-founder of SynapCon Ltd., founder of Schulz&Löw Consulting

Business economist, controller and IT specialist with extensive experience in the implementation and development of business management software. Joachim works as an interim financial manager for a listed US company.

NEWS

Medical Device Regulation (EU MDR)

Initially the new MDR was scheduled to come in force on 26 May 2020. The transition period was extended due to the Covid-19 pandemic. It will now come into force in May 2021. There will not be another transitional period.
As a response manufacturer of medical devices for sale within the EU must adhere to strict guidelines to ensure their products are safe to use. This change will make clinical trials a necessity for many manufacturers.
That´s where we help. Our technology enables SMEs in the medical device sector to anticipate the technology of the “big players” at an unparalleled price-performance ratio. Find out more on how we can help your business get through these changes successfully by contacting sales@synapcon.com.

EasyFeasibility© available for free registration

Our product EasyFeasibility© (https://www.synapcon.com/study-site-selection) is available globally. Hundreds of sponsors, study sites and investigators can vouch for the high value of using platform-based feasibility solutions. Registration on EasyFeasibility© is free for sponsors, study sites and investigators.

New EasyTMF© released

SynapCon launches the next generation of its completely redesigned Clinical Trial Management System EasyClin©. The long-awaited re-release of EasyClin© is finally here and offers updated functionalities in EasyTMF©, our GDPR compliant electronic Trial Master File.

Distribution Partners wanted

SynapCon is looking to further expand its partner network within the European market. We offer above average commissions for sales professional and distributors. To find out more please contact our team at sales@synapcon.com.
Currently we are looking for sales partners in France, Italy, Spain, Belgium, and the Netherlands.

 

Investor Relations

Global market volume > 10 billion $, Annual growth rate 13 %
Target: At least 0.5% market share in 2025
_______________________________________________________
Dear investors, ladies, and gentlemen,
thank you very much for your interest in our company. SynapCon provides state-of- the-art software solutions, that differ greatly from simple platforms solutions. Our business models offer B2B solutions with correspondingly more complex interrelationships than your standard investment case. Therefore, please read the following information about our company, the background, and products, before contacting us.

Philosophy and Products

We look at the foreseeable changes in the value chain thematically, as well as over the foreseeable time horizon. Our products are aimed exclusively at specialists in medical product development and clinical researchers. We exclusively address the area of technical support for clinical studies. This makes us a classic mono-thematic company with a high degree of attractiveness for internationally oriented investors. Our aim is to relieve the burden on health care systems by increasing revenues (e.g. through data sales) and reducing expenditures (medical devices, drugs), as well as to relieving hospital staff by reducing the workload involved in conducting clinical trials (manual data collection, monitoring visits). As a result of these considerations two product lines have been created.
Firstly “EasyClin@suite”, our newly revised clinical trial management system (CTMS) The first modules EasyTMF(c), EasyVideo, EasyISF and EasyFeasibility have been in global distribution since October 2020. Further, subordinate modules will follow in 2021.
Secondly “CLiNSTORM©”, our software based on state-of-the-art database systems and artificial intelligence. “CLiNSTORM©” is currently being implemented and will automate large areas of clinical product development. As a first result and basis for the next steps, we are pleased to present the knowledge collection available free of charge https://www.synapcon.com/blog/).
CLiNSTORM© is a joint venture (UnifiedIQ) between SynapCon and Aifinity.

Approach

We are unique in our consideration of the entire value-added chain of clinical product development and are therefore able to shift the added value created to the developers (producers) and data suppliers (practitioners, patients).

Who we are looking for

Ideally, you are already invested in the medical field and have the expertise to make an appropriate investment decision. Your organization possesses a broad network in life sciences, ideally in clinical trials and pharma.
You have sufficient capital to support a project of this size over several funding rounds. You actively support us in the search for further investors to accelerate the global expansion of our business.
We kindly ask business angels to refrain from contacting us.
A market analysis commissioned by the SynapCon Group from Critical Future clearly shows the enormous potential of our company.
The full presentation (133 pages) and a complete short version of our investment brochure is available on request info(at)synapcon.com.